Korean Cancer Association

Invited Speakers

Plenary Lectures (PL)
Educational Sessions (ES)
Young Investigator Symposium (YIS)
Symposia (SP)
Master Class (MC)
Luncheon Symposia (LS)

Plenary Lectures

Walter Curran, MD, FACR, FASCO	CV
Executive Director, Winship Cancer Institute of Emory University, USA Progress through the new American NCI National Clinical Trials Network: NRG Oncology as a case study

Thomas Gajewski, MD, PhD	CV
Professor, University of Chicago, USA Tumor and host factors regulating immunotherapy efficacy versus resistance

Yeul Hong Kim, MD, PhD	CV
Professor, Korea University College of Medicine, Korea The complex path to cancer precision medicine

Sanghyuk Lee, PhD	CV
Professor, Department of Life Science, Ewha Womans University, Korea Integrative cancer genomics for precision medicine in lung cancer

Educational Sessions (ES)

ES1. Clinical oncology for basic scientists

6/20(T), 09:00-10:40

Kyu-Rae Kim

University of Ulsan College of Medicine

Kyung Won Kim

University of Ulsan College of Medicine

Inkeun Park

Gachon University College of Medicine

Yoon Ji Choi

Korea University College of Medicine

ES2. Recent advances in understanding and treating advanced
GI cancer

6/20(T), 09:00-10:40

Sang-Hoon Ahn

Seoul National University College of Medicine

Sun Jin Park

Kyung Hee University College of Medicine

Hye Jin Kim

Kyungpook National University School of Medicine

Jong-Han Kim

Korea University College of Medicine

ES3. Optimal combination of radiation therapy and immune
checkpoint blockades

6/20(T), 09:00-10:40

SaeGwang Park

Inje University College of Medicine

Jinho Kim

Seoul National University College of Medicine

Kyong Hwa Park

Korea University College of Medicine

Young Investigator Symposium (YIS)

YIS1. Korean Young Investigator Symposium

6/20(T), 09:00-10:40

Jae-Young Kim

Chungnam National University

Han Sang Kim

Yonsei University College of Medicine

Jiheum Paek

Ajou University School of Medicine

HaeYun Jung

Sungkyunkwan University School of Medicine

YIS2. Overseas Young Investigator Symposium

6/21(F), 09:00-10:00

Dong Hyuk Ki

Harvard Medical School/Dana-Farber Cancer Institute, USA

Daniel Sanghoon Shin

David Geffen School of Medicine at UCLA, USA

Youngwook Won

University of Arizona College of Medicine, USA

Symposia (SP)

SP01. Conquering stomach cancer, the major cancer killer
in Korea and Japan

6/20(T), 13:20-15:00

Toshikazu Ushijima

National Cancer Center Research Institute, Japan

Daehee Hwang

Seoul National University School of Biological Sciences

Yoku Hayakawa

The University of Tokyo, Japan

Hoon Hur

Ajou University School of Medicine

SP02. Tissue agnostic drug development

6/20(T), 13:20-15:00

Kenneth Emancipator

MSD, USA

Nicoletta Brega

Bayer, Italy

Myung-Ju Ahn

Sungkyunkwan University School of Medicine

SP03. Updates on head and neck-thyroid oncology

6/20(T), 13:20-15:00

Xiaolei Wang

The Cancer Institute and Hospital, Chinese Academy of Medical Sciences, China

Lai-ping Zhong

Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, China

Chul-Ho Kim

Ajou University School of Medicine

Young Joo Park

Seoul National University College of Medicine

SP04. Immunotherapy for rare cancer

6/20(T), 13:20-15:00

Robbie G. Majzner

Stanford University School of Medicine, USA

Yasushi Fuchimoto

International University of Health and Welfare School of Medicine, Japan

Chang-Yuil Kang

Seoul National University College of Pharmacy

SP05. Strategic plans of improving multicenter clinical trials

6/20(T), 13:20-15:00

Chel Hun Choi

Sungkyunkwan University School of Medicine

Yong Wha Moon

CHA University School of Medicine

Won Park

Sungkyunkwan University School of Medicine

Sokbom Kang

National Cancer Center

SP06. Vascular regulation of cancer progression

6/20(T), 13:20-15:00

Ho Jeong Kwon

Yonsei University

Andreas Fischer

German Cancer Research Center (DKFZ), Germany

Jeong Ho Lee

Korea Advanced Institute of Science and Technology

Injune Kim

Korea Advanced Institute of Science and Technology

SP07. Current status of precision medicine in colorectal cancer

6/20(T), 15:20-17:00

Hideo Baba

Graduate School of Medical Sciences, Kumamoto University, Japan

Toshifumi Wakai

Niigata University Graduate School of Medical and Dental Sciences, Japan

Jihun Kim

University of Ulsan College of Medicine

Jin Won Kim

Seoul National University Bundang Hospital

SP08. Advanced and innovative clinical research

6/20(T), 15:20-17:00

Edward Kim

Atrium Health Levine Cancer Institute, USA

Seung-June Oh

Seoul National University College of Medicine

Jee Hyun Kim

Seoul National University College of Medicine

SP09. Recent precision medicine in gynecologic and breast cancer

6/20(T), 15:20-17:00

Myong Cheol Lim

National Cancer Center

Min Chul Choi

CHA University School of Medicine

Sung Jong Lee

The Catholic University of Korea College of Medicine

Hyung Seok Park

Yonsei University College of Medicine

Woong Ju

Ewha Womans University College of Medicine

SP10. Omics for innovative clinical cancer research

6/20(T), 15:20-17:00

Minho Lee

The Catholic University of Korea

Mirang Kim

Korea Research Institute of Bioscience & Biotechnology

Wonshik Han

Seoul National University College of Medicine

Hyun Goo Woo

Ajou University School of Medicine

SP11. Exchange and cooperation of oncology between South and North Korea

6/20(T), 15:20-17:00

Sin Gon Kim

Korea University College of Medicine

Hee Young Shin

Seoul National University College of Medicine

Yoonsang Lee

Nanum International

SP12. Basic immunology: (Treatment-resistant) Tumor microenvironment

6/21(F), 13:40-15:20

Hun Sik Kim

University of Ulsan College of Medicine

Seung Hyeok Seok

Seoul National University College of Medicine

Tae-Woo Kim

Korea University College of Medicine

SP13. Immune targeted biomarkers in therapeutic decision making

6/21(F), 13:40-15:20

Kyu Sang Lee

Seoul National University College of Medicine

Hyunki Kim

Yonsei University College of Medicine

Jung Ho Kim

Seoul National University Hospital

Tae-Min Kim

The Catholic University of Korea College of Medicine

SP14. Promising anti-cancer drug pipeline in pre-clinical and clinical stages in Korea

6/21(F), 13:40-15:20

Joong Won Lee

Eutilex

Sang-Yoon Lee

HANDOK

SungKu Choi

Ildong Pharmaceutical

SP15. Tumor microenvironment of solid cancer

6/21(F), 13:40-15:20

Semin Lee

Ulsan National Institute of Science and Technology

Darren Reece Williams

Gwangju Institute of Science and Technology

Atsushi Enomoto

Nagoya University, Japan

Chan Kim

CHA University School of Medicine

SP16. Underlying mechanisms of novel cellular therapies

6/21(F), 15:40-17:20

Chantale Bernatchez

MD Anderson Cancer Center, USA

Cara Haymaker

MD Anderson Cancer Center, USA

Chan-Young Ock

Seoul National University Hospital

SP17. Microbiology and microbiome in cancer

6/21(F), 15:40-17:20

Dong-Gun Lee

The Catholic University of Korea College of Medicine

Ju Sun Song

Green Cross Genome

Hansoo Park

Gwangju Institute of Science and Technology

SP18. Current practice and dilemma in oligometastatic disease of
lung cancer

6/21(F), 15:40-17:20

Dong Hoon Shin

Pusan National University School of Medicine

Hyun Koo Kim

Korea University College of Medicine

Yang-Gun Suh

National Cancer Center

Sook Hee Hong

The Catholic University of Korea College of Medicine

SP19. 암관련학회협의체 심포지엄

6/21(F), 15:40-17:20

Jung Hye Kwon

Hallym University College of Medicine

Dae Ho Lee

University of Ulsan College of Medicine

Ji Soo Park

Yonsei University College of Medicine

Master Classes (MC)

MC1. Recent updates in the development of immune-therapy for cancer treatment

6/20(T), 13:20-15:00

Wallace Mondesire

MSD, USA

Tae-Min Kim

The Catholic
University of Korea
College of Medicine

Victoria Robinson

MSD, USA

MC2. GC academy- Special talk for antiangiogenic agents in mGC treatment

6/20(T), 15:20-17:00

Jin-Soo Kim

Seoul National University Boramae Medical Center

Sun Young Rha

Yonsei University College of Medicine

Keun-Wook Lee

Seoul National University College of Medicine

MC3. How to generate and utilize RWE (real-world evidence) in oncology

6/21(F), 13:40-15:20

Dae Ho Lee

University of Ulsan College of Medicine

Ju-Young Shin

Sungkyunkwan University School of Pharmacy

Camille Perret

Roche, Switzerland

Luncheon Symposia (LS)

Luncheon Symposium 1 (Sanofi Genzyme)

6/20(T), 12:20-13:20

Julien Taieb	CV
Georges Pompidou European Hospital, Sorbonne Paris-Cite, Universite Paris-Descartes, France Individualized treatment decision for optimal sequence in mCRC, with aflibercept

Luncheon Symposium 2 (Servier)

6/20(T), 12:20-13:20

Changhoon Yoo	CV
University of Ulsan College of Medicine Liposomal irinotecan, new hope for the treatment of metastatic pancreatic cancer

Luncheon Symposium 3 (AstraZeneca)

6/20(T), 12:20-13:20

Tae Min Kim	CV
Seoul National University College of Medicine Cutting-edge front-line treatment for advanced non-small cell lung cancer

Luncheon Symposium 4 (Pfizer)

6/20(T), 12:20-13:20

Takashi Seto	CV
Kyushu Cancer Center, Japan Therapeutic strategy for maximizing overall survival for ALK/ROS1+ NSCLC

Luncheon Symposium 5 (MSD)

6/21(F), 11:50-12:50

Ji Hyun Park	CV
Konkuk University School of Medicine 'Standard of Care' to 'Standard of Survival': Unfolding the quantum leap in mNSCLC

Luncheon Symposium 6 (Roche)

6/21(F), 11:50-12:50

Ji-Youn Han	CV
National Cancer Center The evolving power of immunotherapy: Atezolizumab in advanced lung cancer

Luncheon Symposium 7 (Lilly)

6/21(F), 11:50-12:50

Keun-Wook Lee	CV
Seoul National University College of Medicine An optimal post-progression treatment option to improve advanced gastric cancer patient outcomes: Clinical experiences with ramucirumab

top